유럽 연합 - 슬로바키아어 - EMA (European Medicines Agency)

bene-arzneimittel gmbh - pentosan polysulfát sodný - cystitídy, intersticiálna - urologika - elmiron je indikovaný na liečbu močového mechúra bolesti syndróm charakterizovaný buď glomerulations alebo hunner's lézií u dospelých so stredne ťažkou až ťažkou bolesťou, naliehavosť a frekvencia močenia.

유럽 연합 - 슬로바키아어 - EMA (European Medicines Agency)

pfizer europe ma eeig - dacomitinib monohydrát - karcinóm, pľúc bez malých buniek - antineoplastické činidlá - vizimpro, ako monotherapy je uvedený na prvej línie liečby dospelých pacientov s lokálne pokročilým alebo metastatickým non malé bunky rakoviny pľúc (nsclc) s epidermálnych growth factor receptor (egfr) aktivácia mutácie.

슬로바키아 - 슬로바키아어 - ŠÚKL (Štátny ústav pre kontrolu liečiv)

teoxane s.a. les charmilles rue de lyon 105 ch-1203 geneva Švajčiarsko -

슬로바키아 - 슬로바키아어 - ŠÚKL (Štátny ústav pre kontrolu liečiv)

teoxane s.a. les charmilles rue de lyon 105 ch-1203 geneva Švajčiarsko -

슬로바키아 - 슬로바키아어 - ŠÚKL (Štátny ústav pre kontrolu liečiv)

3m deutschland gmbh carl-schurz-strasse 1 41460 neuss nemecko -

슬로바키아 - 슬로바키아어 - ŠÚKL (Štátny ústav pre kontrolu liečiv)

ulti med products (belgium) bvba., honzebŕoekstraat 137 roeselare belgicko -

유럽 연합 - 슬로바키아어 - EMA (European Medicines Agency)

daiichi sankyo europe gmbh - trastuzumab deruxtecan - neoplazmy prsníkov - antineoplastické činidlá - breast cancerher2-positive breast cancerenhertu as monotherapy is indicated for the treatment of adult patients with unresectable or metastatic her2-positive breast cancer who have received one or more prior anti-her2-based regimens. her2-low breast cancerenhertu as monotherapy is indicated for the treatment of adult patients with unresectable or metastatic her2-low breast cancer who have received prior chemotherapy in the metastatic setting or developed disease recurrence during or within 6 months of completing adjuvant chemotherapy (see section 4. non-small cell lung cancer (nsclc)enhertu as monotherapy is indicated for the treatment of adult patients with advanced nsclc whose tumours have an activating her2 (erbb2) mutation and who require systemic therapy following platinum-based chemotherapy with or without immunotherapy. gastric cancerenhertu as monotherapy is indicated for the treatment of adult patients with advanced her2-positive gastric or gastroesophageal junction (gej) adenocarcinoma who have received a prior trastuzumab-based regimen.

유럽 연합 - 슬로바키아어 - EMA (European Medicines Agency)

boehringer ingelheim vetmedica gmbh - eprinomectin, esafoxolaner, praziquantel - eprinomectin, combinations, , avermectins, antiparasitic products, insecticides and repellents - mačky - for cats with, or at risk from mixed infections by cestodes, nematodes and ectoparasites. veterinárneho lieku je výlučne uvedená pri všetkých troch skupín sú zamerané na rovnaký čas.

유럽 연합 - 슬로바키아어 - EMA (European Medicines Agency)

janssen-cilag international n.v.    - amivantamab - karcinóm, pľúc bez malých buniek - antineoplastické činidlá - rybrevant as monotherapy is indicated for treatment of adult patients with locally advanced or metastatic non-small cell lung cancer (nsclc) with activating epidermal growth factor receptor (egfr) exon 20 insertion mutations, after failure of platinum-based chemotherapy.

슬로바키아 - 슬로바키아어 - ŠÚKL (Štátny ústav pre kontrolu liečiv)

viomedex ltd units 13 swan barn business centre, old swan lane, east sussex bn27 2by hailsham spojené kráľovstvo veľkej británie a severného Írska -